Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | CDC7 | O00311 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | PRKACA | P17612 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.35 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphosphate SCHEMBL8438673 | 0.85 | HCAR3 (0.35) | ALDH1A1RAB9AKDM4EHCAR3SLC2A1 | |
| SCHEMBL10865972 | 0.79 | ADORA2A (0.30) | ALDH1A1 | |
| SCHEMBL4973928 | 0.77 | HCAR3 (0.40) | ALDH1A1RAB9AKDM4EHCAR3SLC2A1 | |
| SCHEMBL4306636 | 0.76 | DYRK1A (0.31) | — | |
| SCHEMBL236001 | 0.76 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL65489 | 0.76 | CACNA1C (0.42) | ALDH1A1HCAR3CA1CA2CA9 | |
| SCHEMBL19692262 | 0.76 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL17372301 | 0.76 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL3680113 | 0.73 | POLB (0.41) | ALDH1A1RAB9AKDM4ECDC7ROCK2 | |
| SCHEMBL3798154 | 0.73 | ALDH1A1 (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116987495-A | Construction and application of protein membrane macromolecular probe for biological detection | 江南大学 | 2023-11-03 | — | — | CN | claimed |
| WO-2023114963-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY LABELING SECONDARY AMINES | EMORY UNIVERSITY (US) | 2023-06-22 | — | — | WO | claimed |
| CN-114807328-A | Method for marking and identifying single-base resolution DNA | 浙江大学 | 2022-07-29 | — | — | CN | claimed |
| CN-112301118-B | Method and kit for simultaneously obtaining RNA abundance and active RNA polymerase sites in full transcriptome range | 浙江大学 | 2022-05-13 | — | — | CN | claimed |
| US-20020160969-A1 | Nucleosides and oligonucleotides containing boron clusters | DEPARTMENT OF VETERANS AFFAIRS | 2002-10-31 | — | — | US | claimed |
| EP-1113020-A2 | Nucleosides and oligonucleotides containing boron clusters | EMORY UNIVERSITY (US) | 2001-07-04 | — | — | EP | claimed |
| US-6180766-B1 | OLIGONUCLEOTIDE WITH UNCHARGED INTERNUCLEOTIDE LINKAGE(S) OF 3',5'-O,O-((CARBORAN-1-YL-METHYL)PHOSPHONATE); MADE BY REACTING O-METHYL(O-CARBORAN-1-YL)METHYL PHOSPHONATE WITH PROTECTED NUCLEOSIDE; USE IN BORON NEUTRON CAPTURE THERAPY | DEPARTMENT OF VETERANS AFFAIRS | 2001-01-30 | — | — | US | claimed |
| EP-0731808-A4 | NUCLEOSIDES AND OLIGONUCLEOTIDES CONTAINING BORON CLUSTERS | UNIV EMORY (US) | 1997-04-02 | — | — | EP | claimed |
| EP-0731808-A1 | NUCLEOSIDES AND OLIGONUCLEOTIDES CONTAINING BORON CLUSTERS | EMORY UNIVERSITY (US) | 1996-09-18 | — | — | EP | claimed |
| WO-1995015333-A1 | NUCLEOSIDES AND OLIGONUCLEOTIDES CONTAINING BORON CLUSTERS | EMORY UNIVERSITY (US) | 1995-06-08 | — | — | WO | claimed |
| EP-4720339-A1 | METHODS FOR DOUBLE-STRANDED SEQUENCING BY SYNTHESIS | Illumina, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20240401129-A1 | METHODS FOR DOUBLE-STRANDED SEQUENCING BY SYNTHESIS | ILLUMINA, INC. (US) | 2024-12-05 | — | — | US | disclosed |
| WO-2024249591-A1 | METHODS FOR DOUBLE-STRANDED SEQUENCING BY SYNTHESIS | ILLUMINA, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-4457364-A1 | METHODS OF NUCLEIC ACID SEQUENCING USING SURFACE-BOUND PRIMERS | Illumina, Inc. (US) | 2024-11-06 | — | — | EP | disclosed |
| US-20240229036-A9 | NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN | KNC LABORATORIES CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20010044529-A1 | Thermolabile phosphorus protecting groups, associated intermediates and methods of use | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-11-22 | — | — | US | disclosed |
| WO-2000056749-A1 | N-ACYLPHOSPHORAMIDITES AND THEIR USE IN OLIGONUCLEOTIDE SYNTHESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-09-28 | — | — | WO | disclosed |
| EP-0421777-B1 | Further antiviral pyrimidine nucleosides | UNIV BIRMINGHAM (GB) | 1996-02-28 | — | — | EP | disclosed |
| WO-1991004982-A1 | FURTHER ANTIVIRAL PYRIMIDINE NUCLEOSIDES | UNIVERSITY OF BIRMINGHAM (GB) | 1991-04-18 | — | — | WO | disclosed |
| EP-0421777-A1 | Further antiviral pyrimidine nucleosides | THE UNIVERSITY OF BIRMINGHAM (GB) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020160969-A1 | Nucleosides and oligonucleotides containing boron clusters | NUDT1, NTPCR, NAMPT | ALDH1A1 4697/4885RAB9A 3256/4885KDM4E 4815/4885 |
| US-20010044529-A1 | Thermolabile phosphorus protecting groups, associated intermediates and methods of use | POLR2H, POLL, POLR1A | ALDH1A1 1410/4885RAB9A 3726/4885KDM4E 4508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.